Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Abbott Slashes More Jobs

by Lisa M. Jarvis
January 31, 2011 | A version of this story appeared in Volume 89, Issue 5

Abbott Laboratories is shedding 2% of its workforce, or about 1,900 jobs, across its U.S. commercial and manufacturing operations. More than half of the cuts will come from operations in northern Illinois, a manufacturing hub for Abbott. In a conference call, Abbott CEO Miles D. White said the restructuring was driven by several factors: the slow recovery of the global economy, costs associated with health care reform, European pricing pressures, and a tougher regulatory environment. These cuts mirror the 3,000 jobs lost in Europe last year after Abbott’s acquisition of Solvay Pharmaceuticals.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.